We always have studies for different diabetes medications and devices at Grunberger Diabetes Institute.

Do you or one of your loved ones have diabetes which is not well controlled?

If so, you may qualify to participate in a research study. There is no charge to participate in any of the studies.

Depending on the study, qualified participants may receive study-related:

  • Medical exams, lab work (blood and urine), and ECGs
  • Blood sugar monitoring supplies
  • Study medication
  • Compensation for travel

Participants will be asked to complete office visits depending on the study they are enrolled in.

To learn more or to find out which study is best for you, please contact us at Grunberger Diabetes institute:

Contact us248-335-7740

Igor Kupriyanchik
Igor KupriyanchikDoctor
received his medical degree from the Far Eastern State Medical University, located in Khabarovsk, Russia. After the completion of training for internal medicine at L’viv National Medical University in Ukraine, he worked as a staff physician in L’viv Clinical Hospital of the Ministry of Railways of Ukraine.

Before joining GDI in the role of a Clinical Research Coordinator, Dr. Kupriyanchik worked for more than 7 years as a Lead Clinical Research Coordinator in the Emergency Medicine Department of Henry Ford Hospital. He was involved in Registry Data Collection studies, the development of biomarkers for diagnosing and monitoring acute coronary syndrome, as well as in multiple pharmaceutical clinical adult studies on asthma, hypertension, COPD, acute and chronic heart failure.

 Active NEW Studies

Enrollment for these studies is currently open.

Comparison of U-500 Insulin delivery: insulin pump vs. injections

  • Route – Insulin pump vs. multiple injections
  • Visits – 10 scheduled office visits plus 7 telephone visits
  • Duration – 29 weeks

Study of the Enlite Sensor-Augmented Insulin Pump System

Study Product – MiniMed® 530G insulin pump system

  • Patients who are currently using sensor-augmented pump therapy for at least 90 days.
  • Visits – 5 office visits
  • Duration – 1 year

Interested in participating in a study?

Call us at 248-335-7740 or send us a note.

Ongoing Studies

Enrollment for these studies is closed.

Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Study Drug – Exenatide (Bydureon)

  • Route – Injection under the skin once weekly
  • Visits – After initial screening, every six months

Efficacy and safety of Adding Ertugliflozin or Glimepiride in Patients With Type 2 Diabetes Mellitus whose Glucose Is Not Well Controlled on Metformin

Study drug – Ertugliflozin

  • Route – Pill, once daily
  • Visits – up to 14 scheduled office visits
  • Duration – 104 weeks

Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease

Study drug – Ertugliflozin

  • Route – Pill, once daily
  • Visits – up to 12 scheduled office visits
  • Duration – 52 weeks

Study of adding Sotagliflozin to Insulin Therapy in Type 1 Diabetes

  • Route – Pill, once daily
  • Visits – 7 scheduled office visits
  • Duration – 28 weeks

Grunberger Diabetes Institute and Research:

Grunberger Diabetes Institute has a long successful history of conducting diabetes clinical studies. Dr. George Grunberger has more than 35 years of experience in this field. Hundreds of patients have participated in many different clinical research studies over the years. Excellent outpatient facility, thorough information on research, flexible appointment scheduling and close monitoring of participants make us special.